Autres langues Inovio Pharmaceuticals, Inc.

Actions

INO

US45773H4092

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
12 ^USD	-6,18 %		+12,68 %	+96,08 %

14/05	INOVIO PHARMACEUTICALS, INC. : Opinion positive de Stephens Inc.	ZM
13/05	Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Inovio: Q1 Earnings Snapshot	13/05
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights	13/05
Inovio Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
INOVIO Reports Inducement Grants Under Inducement Plan	01/05
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024	29/04
INOVIO to Participate in Upcoming Investor Conferences in May	29/04
Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell	16/04
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants	16/04
Top Premarket Decliners	16/04
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	16/04
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine	26/03
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	07/03
Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024	21/02
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	07/02
INOVIO Reports Inducement Grant Under Inducement Plan	02/02
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split	23/01
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader	22/01
Inovio Pharmaceuticals, Coherus BioSciences to Collaborate on Potential Throat Cancer Treatment	04/01
INOVIO and Coherus Announces Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI?? (toripalimab-Ttzi)	04/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Inovio Pharmaceuticals, Inc.

Actions

INO

US45773H4092

Autres langues

Filtres